BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 21378402)

  • 1. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
    Buch MH; Smolen JS; Betteridge N; Breedveld FC; Burmester G; Dörner T; Ferraccioli G; Gottenberg JE; Isaacs J; Kvien TK; Mariette X; Martin-Mola E; Pavelka K; Tak PP; van der Heijde D; van Vollenhoven RF; Emery P;
    Ann Rheum Dis; 2011 Jun; 70(6):909-20. PubMed ID: 21378402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.
    Dudler J; Finckh A; Kyburz D; Langenegger T; Möller B; Schmiedel U; Walker UA
    Swiss Med Wkly; 2010; 140():w13073. PubMed ID: 20648402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: When should we use rituximab to treat RA?
    Yazici Y
    Nat Rev Rheumatol; 2011 May; 7(7):379-80. PubMed ID: 21629243
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab for the treatment of rheumatoid arthritis: an update.
    Mok CC
    Drug Des Devel Ther; 2013 Dec; 8():87-100. PubMed ID: 24403823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statement on the use of rituximab in patients with rheumatoid arthritis.
    Smolen JS; Keystone EC; Emery P; Breedveld FC; Betteridge N; Burmester GR; Dougados M; Ferraccioli G; Jaeger U; Klareskog L; Kvien TK; Martin-Mola E; Pavelka K;
    Ann Rheum Dis; 2007 Feb; 66(2):143-50. PubMed ID: 17068064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ].
    Martín Mola E; Hernández B; García-Arias M; Alvaro-Gracia JM; Balsa A; Reino JG; Marenco de la Fuente JL; Martínez-Taboada V; Ivorra JA; Sanmartí R;
    Reumatol Clin; 2011; 7(1):30-44. PubMed ID: 21794777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.
    Smolen JS; Landewé R; Breedveld FC; Buch M; Burmester G; Dougados M; Emery P; Gaujoux-Viala C; Gossec L; Nam J; Ramiro S; Winthrop K; de Wit M; Aletaha D; Betteridge N; Bijlsma JW; Boers M; Buttgereit F; Combe B; Cutolo M; Damjanov N; Hazes JM; Kouloumas M; Kvien TK; Mariette X; Pavelka K; van Riel PL; Rubbert-Roth A; Scholte-Voshaar M; Scott DL; Sokka-Isler T; Wong JB; van der Heijde D
    Ann Rheum Dis; 2014 Mar; 73(3):492-509. PubMed ID: 24161836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids in rheumatoid arthritis: current status and future studies.
    Hua C; Buttgereit F; Combe B
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.
    Lee YH; Bae SC; Song GG
    Rheumatol Int; 2011 Nov; 31(11):1493-9. PubMed ID: 20473756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
    Smolen JS; Schoels MM; Nishimoto N; Breedveld FC; Burmester GR; Dougados M; Emery P; Ferraccioli G; Gabay C; Gibofsky A; Gomez-Reino JJ; Jones G; Kvien TK; Murakami M; Betteridge N; Bingham CO; Bykerk V; Choy EH; Combe B; Cutolo M; Graninger W; Lanas A; Martin-Mola E; Montecucco C; Ostergaard M; Pavelka K; Rubbert-Roth A; Sattar N; Scholte-Voshaar M; Tanaka Y; Trauner M; Valentini G; Winthrop KL; de Wit M; van der Heijde D
    Ann Rheum Dis; 2013 Apr; 72(4):482-92. PubMed ID: 23172750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell therapies in established rheumatoid arthritis.
    Leandro MJ; Becerra-Fernandez E
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):535-48. PubMed ID: 22137923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety].
    Hernández-Cruz B; García-Arias M; Ariza Ariza R; Martín Mola E
    Reumatol Clin; 2011; 7(5):314-22. PubMed ID: 21925447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell therapies for rheumatoid arthritis.
    Scher JU
    Bull NYU Hosp Jt Dis; 2012; 70(3):200-3. PubMed ID: 23259629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of rituximab in patients with rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2010; 57(2):158-60. PubMed ID: 21875022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.
    Looney RJ
    Drugs; 2006; 66(5):625-39. PubMed ID: 16620141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab: a new therapeutic alternative in rheumatoid arthritis.
    Sibilia J; Gottenberg JE; Mariette X
    Joint Bone Spine; 2008 Oct; 75(5):526-32. PubMed ID: 18571968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link?
    van Sijl AM; van der Weele W; Nurmohamed MT
    Curr Pharm Des; 2014; 20(4):496-9. PubMed ID: 23565629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis.
    Pehlivan Y; Kisacik B; Bosnak VK; Onat AM
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23341582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register.
    Sebastiani M; Anelli MG; Atzeni F; Bazzani C; Farina I; Fedele AL; Favalli EG; Fineschi I; Cino N; Dal Forno I; Gasparini S; Cassarà E; Giardina R; Bruschi E; Addimanda O; Cassone G; Lopriore S; Sarzi-Puttini P; Filippini M; Pignatti F; Gremese E; Biggioggero M; Manganelli S; Amato G; Caimmi C; Salaffi F; Iannone F; Ferri C; Sandri G; Lapadula G; Gorla R; Govoni M; Ferraccioli G; Marchesoni A; Galeazzi M; Foti R; Carletto A; Cantini F; Triolo G; Epis OM; Salvarani C;
    Joint Bone Spine; 2014 Dec; 81(6):508-12. PubMed ID: 25082646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
    Furst DE; Keystone EC; Braun J; Breedveld FC; Burmester GR; De Benedetti F; Dörner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Sieper J; Singer NG; Smolen JS; Van Riel PL; Weisman MH; Winthrop K
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i2-45. PubMed ID: 22460137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.